Shirley Latest News (New York, United States)

Creative Biolabs updated strategies in order to help achieve success in immunotherapy discovery.

A newly released market research reports on the prosperous future of exosome research.

Creative Biolabs expressed hopes that further progress could be made in the field of exosome research.

Creative Diagnostics, a global leader in providing raw materials, antibodies, and reagents for the biotechnology industry, recently introduced a series of HPV vaccine development products.

A recent market report reveals the huge potential of exosome research, which is gaining mounting research fever across the industry.

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics recently introduced Hemagglutination Inhibition Assay services to determine relative concentrations of viruses, bacteria, or antibodies.

Creative Biolabs identifies a suite of exosome services to advance basic research based on microRNAs-associated extracellular vesicles as novel diagnostic tools for melanoma.

Creative BioMart Optogenetics, a sub-brand of Creative BioMart that focused in the field related to genetics and biological product production, recently established an integrated neuroscience technology platform that incorporated cell culture, model...